Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis.

Pancreas
Takuji OkusakaCommittee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society

Abstract

Clinical Practice Guidelines for Pancreatic Cancer were first published in 2006 by the Japan Pancreas Society, and they were revised in 2009, 2013, and 2016. In July 2019, the Clinical Practice Guidelines for Pancreatic Cancer 2019 were newly revised in Japanese. For this version, we developed the new guidelines according to the Minds Manual for Guideline Development 2017, which includes the concepts of GRADE (Grading Recommendations Assessment, Development, and Evaluation), to enable a better understanding of the current guidelines. The guidelines show algorithms for the diagnosis, treatment, and chemotherapy of pancreatic cancer and address 7 subjects: diagnosis, surgical therapy, adjuvant therapy, radiation therapy, chemotherapy, stent therapy, and supportive and palliative medicine. They include 56 clinical questions and 84 statements. There are statements corresponding to clinical questions, evidence levels, recommendation strengths, and agreement rates. These guidelines represent the most standard clinical and practical management guidelines at this time in Japan. This is the English synopsis of the Clinical Practice Guidelines for Pancreatic Cancer 2019 in Japanese and is an attempt to disseminate the Japanese guidelines...Continue Reading

References

Jul 2, 2011·Japanese Journal of Clinical Oncology·Koji YamaguchiUNKNOWN Committee for Revision of Clinical Guidelines for Pancreatic Cancer of Japan Pancreas Society
Sep 11, 2014·Japanese Journal of Clinical Oncology·Koji YamaguchiUNKNOWN Committee for revision of clinical guidelines for pancreatic cancer of Japan Pancreas Society
Apr 21, 2017·Pancreas·Koji YamaguchiUNKNOWN Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society

❮ Previous
Next ❯

Citations

Aug 29, 2020·Surgery Today·Yoshihiro MiyasakaMasafumi Nakamura
Dec 4, 2020·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Jessica LindemannEduard Jonas
Feb 4, 2021·Annals of Gastroenterological Surgery·Keinosuke IshidoTaiichi Wakiya
Dec 18, 2020·Diagnostics·Keisuke KuriharaAkinori Shimizu
Apr 1, 2021·JAMA Surgery·Michail N MavrosTimothy M Pawlik
Jul 10, 2021·Cancer Treatment Reviews·Stefano PartelliPhilip Poortmans
Jul 31, 2021·Journal of Hepato-biliary-pancreatic Sciences·Daisuke HashimotoMitsugu Sekimoto

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
dissection
pancreatectomy
surgical resection

Software Mentioned

AGREE
Minds

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pancreas
Koji YamaguchiCommittee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society
Japanese Journal of Clinical Oncology
Koji YamaguchiCommittee for revision of clinical guidelines for pancreatic cancer of Japan Pancreas Society
Nihon rinsho. Japanese journal of clinical medicine
Koji Yamaguchi
Health Research Policy and Systems
Holger J SchünemannWHO Advisory Committee on Health Research
© 2021 Meta ULC. All rights reserved